Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Design and characterization of α1-antitrypsin variants for treatment of contact system–driven thromboinflammation

Steven de Maat, Wariya Sanrattana, Reiner K. Mailer, Naomi M. J. Parr, Martin Hessing, Robert M. Koetsier, Joost C. M. Meijers, Gerard Pasterkamp, Thomas Renné, Coen Maas

Blood (2019) 134 (19): 1658–1669.

https://doi.org/10.1182/blood.2019000481

Published: 2019

Includes: Supplemental data

Journal Articles

In vitro evaluation of factor IX as novel treatment for factor XI deficiency

Kamran Bakhtiari, Joost C. M. Meijers

Blood (2019) 134 (6): 573–575.

https://doi.org/10.1182/blood.2019000681

Published: 2019

Journal Articles

Defective TAFI activation in hemophilia A mice is a major contributor to joint bleeding

Tine Wyseure, Esther J. Cooke, Paul J. Declerck, Niels Behrendt, Joost C. M. Meijers, Annette von Drygalski, Laurent O. Mosnier

Blood (2018) 132 (15): 1593–1603.

https://doi.org/10.1182/blood-2018-01-828434

Published: 2018

Includes: Supplemental data

Journal Articles

Prochemerin processing by factor XIa

Joost C. M. Meijers

Blood (2018) 131 (3): 275–276.

https://doi.org/10.1182/blood-2017-12-818989

Published: 2018

Journal Articles

Contact ignition by single-chain XIIa

Joost C. M. Meijers, Alvin H. Schmaier

Blood (2017) 129 (11): 1411–1412.

https://doi.org/10.1182/blood-2017-02-763532

Published: 2017

Journal Articles

Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking

James R. Byrnes, Cédric Duval, Yiming Wang, Caroline E. Hansen, Byungwook Ahn, Micah J. Mooberry, Martha A. Clark, Jill M. Johnsen, Susan T. Lord, Wilbur A. Lam, Joost C. M. Meijers, Heyu Ni, Robert A. S. Ariëns, Alisa S. Wolberg

Blood (2015) 126 (16): 1940–1948.

https://doi.org/10.1182/blood-2015-06-652263

Published: 2015

Includes: Multimedia, Supplemental data

Journal Articles

A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function

Marisa L. R. Cunha, Kamran Bakhtiari, Jorge Peter, J. Arnoud Marquart, Joost C. M. Meijers, Saskia Middeldorp

Blood (2015) 125 (11): 1822–1825.

https://doi.org/10.1182/blood-2014-08-592733

Published: 2015

Includes: Supplemental data

Journal Articles

No contact, no thrombosis?

Joost C. M. Meijers

Blood (2014) 123 (11): 1629.

https://doi.org/10.1182/blood-2014-01-549691

Published: 2014

Journal Articles

BH3-only protein Noxa regulates apoptosis in activated B cells and controls high-affinity antibody formation

Felix M. Wensveen, Ingrid A. M. Derks, Klaas P. J. M. van Gisbergen, Alex M. de Bruin, Joost C. M. Meijers, HaciAli Yigittop, Martijn A. Nolte, Eric Eldering, René A. W. van Lier

Blood (2012) 119 (6): 1440–1449.

https://doi.org/10.1182/blood-2011-09-378877

Published: 2012

Includes: Supplemental data

Journal Articles

Increased coagulation factor VIII activity in patients with familial hypercholesterolemia

Roeland Huijgen, John J. P. Kastelein, Joost C. M. Meijers

Blood (2011) 118 (26): 6990–6991.

https://doi.org/10.1182/blood-2011-10-386227

Published: 2011

Journal Articles

β 2 -Glycoprotein I: a novel component of innate immunity

Çetin Ağar, Philip G. de Groot, Matthias Mörgelin, Stephanie D. D. C. Monk, Gwendolyn van Os, Johannes H. M. Levels, Bas de Laat, Rolf T. Urbanus, Heiko Herwald, Tom van der Poll, Joost C. M. Meijers

Blood (2011) 117 (25): 6939–6947.

https://doi.org/10.1182/blood-2010-12-325951

Published: 2011

Journal Articles

The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver

Ton Lisman, Marco Platto, Joost C. M. Meijers, Elizabeth B. Haagsma, Michele Colledan, Robert J. Porte

Blood (2011) 117 (6): 2070–2072.

https://doi.org/10.1182/blood-2010-08-300913

Published: 2011

Includes: Supplemental data

Journal Articles

Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk

Hong Zhang, Ester C. Löwenberg, Jeffrey R. Crosby, A. Robert MacLeod, Chenguang Zhao, Dacao Gao, Chris Black, Alexey S. Revenko, Joost C. M. Meijers, Erik S. Stroes, Marcel Levi, Brett P. Monia

Blood (2010) 116 (22): 4684–4692.

https://doi.org/10.1182/blood-2010-04-277798

Published: 2010

Includes: Multimedia, Supplemental data

Journal Articles

β 2 -Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome

Çetin Ağar, Gwendolyn M. A. van Os, Matthias Mörgelin, Richard R. Sprenger, J. Arnoud Marquart, Rolf T. Urbanus, Ronald H. W. M. Derksen, Joost C. M. Meijers, Philip G. de Groot

Blood (2010) 116 (8): 1336–1343.

https://doi.org/10.1182/blood-2009-12-260976

Published: 2010

Journal Articles

Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1

Mirjam E. Meltzer, Ton Lisman, Philip G. de Groot, Joost C. M. Meijers, Saskia le Cessie, Carine J. M. Doggen, Frits R. Rosendaal

Blood (2010) 116 (1): 113–121.

https://doi.org/10.1182/blood-2010-02-267740

Published: 2010

Includes: Supplemental data

Journal Articles

Feedback controversy stops here

Joost C. M. Meijers

Blood (2009) 114 (2): 235.

https://doi.org/10.1182/blood-2009-04-217117

Published: 2009

Journal Articles

Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation

Pauline F. Marx, T. Harma C. Brondijk, Tom Plug, Roland A. Romijn, Wieger Hemrika, Joost C. M. Meijers, Eric G. Huizinga

Blood (2008) 112 (7): 2803–2809.

https://doi.org/10.1182/blood-2008-03-146001

Published: 2008

Journal Articles

Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia

Michiel E. Stegenga, Saskia N. van der Crabben, Regje M. E. Blümer, Marcel Levi, Joost C. M. Meijers, Mireille J. Serlie, Michael W. T. Tanck, Hans P. Sauerwein, Tom van der Poll

Blood (2008) 112 (1): 82–89.

https://doi.org/10.1182/blood-2007-11-121723

Published: 2008

Journal Articles

Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII

Carine J. M. Doggen, Frits R. Rosendaal, Joost C. M. Meijers

Blood (2006) 108 (13): 4045–4051.

https://doi.org/10.1182/blood-2005-12-023697

Published: 2006

Journal Articles

KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium

Rob J. Dekker, Reinier A. Boon, Mariska G. Rondaij, Astrid Kragt, Oscar L. Volger, Yvonne W. Elderkamp, Joost C. M. Meijers, Jan Voorberg, Hans Pannekoek, Anton J. G. Horrevoets

Blood (2006) 107 (11): 4354–4363.

https://doi.org/10.1182/blood-2005-08-3465

Published: 2006

Includes: Supplemental data

NARROW

Design and characterization of α1-antitrypsin variants for treatment of contact system–driven thromboinflammation

In vitro evaluation of factor IX as novel treatment for factor XI deficiency

Defective TAFI activation in hemophilia A mice is a major contributor to joint bleeding

Prochemerin processing by factor XIa

Contact ignition by single-chain XIIa

Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking

A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function

No contact, no thrombosis?

BH3-only protein Noxa regulates apoptosis in activated B cells and controls high-affinity antibody formation

Increased coagulation factor VIII activity in patients with familial hypercholesterolemia

β 2 -Glycoprotein I: a novel component of innate immunity

The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver

Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk

β 2 -Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome

Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1

Feedback controversy stops here

Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation

Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia

Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII

KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only